Corporate Banner
Satellite Banner
Technology Networks Header
Monday, November 24, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
GCT Selects CRO Starter Kit™ PSA Platform by Flex Databases
Thursday, February 13, 2014
CRO Starter Kit™ provide increased efficiency and speed in running clinical research projects.

Crown Bioscience to Showcase Novel “in life” Platforms for Oncology
Tuesday, February 11, 2014
Company will highlight its expertise in Oncology Drug Discovery at AACR 2014.

Fluxion Biosciences Expands IsoFlux Discovery Services Capabilities with Clinical Sample Procurement
Monday, February 10, 2014
New capability provides a full-service option for circulating tumor cell studies.

Nanotherapeutics Selects GE Healthcare Life Sciences Technologies
Thursday, February 06, 2014
FlexFactory™ biomanufacturing platform selected to perform a central role in NANO-ADM Center.

Cotton Rat RSV Model Launched by Noble Life Sciences and IBT Bioservices
Friday, January 31, 2014
Cotton rat model for preclinical studies of respiratory syncytial virus therapies and vaccines.

SCHOTT Assists the Pharmaceutical Industry on Tracking Pharmaceutical Tubing
Thursday, January 23, 2014
Company issues its 1 millionth certificate for its FIOLAX® glass tubing.

FDA, EMA Extend Licenses for Aptiv Solutions ADDPLAN® Software
Wednesday, January 08, 2014
FDA purchases novel ADDPLAN® DF Software for improved evaluation of Phase II dose-finding trials.

EyeTechCare Doubles the Number of Health Care Facilities in France with the EyeOP1 Device
Thursday, January 02, 2014
The EyeOp1 device is now available in ten centers across France, with this figure expected to double in 2014.

TELOS MicroPlate™ from Kinesis – a versatile 96-well SPE format for small volume biological fluid samples
Monday, December 16, 2013
The TELOS MicroPlate™ is a versatile 96-well plate for the extraction of drug molecules from small volume biological fluid samples.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 295
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
SELECTBIO
SELECTBIO Market Reports
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv